The increased secretion of leptin promotes metastasis by increasing the expression of epithelial–mesenchymal transformation (EMT)- and metastasis-associated genes (SERPINE1, MMP-2, and IL-6) in breast cancer cells [136]. Here, LEP is linked to breast carcinoma.